BetterLife Pharma Inc (QB) (BETRF) 시세

First... invest in MNMD... profit on FDA approval of their MM-120 candidate over the next 12 months. Then pour those winning here as BETRF gets IND and P1 of their drug candidate BETR-001....

Thank me later.

Hahaha, same. Down $200 bucks, averaged at .24. No sweat! .07, you say? Alright, count me in. I'll double down with ya :)

Now it's even lower - wild. I'll hold. If it drops below .07 I'm going to load up like a fiend.

Started collecting my bag at .40 Hindsight is 20/20, but I'm loving the price below .20.

2 monster 2000% runs in the last 10 years, as well as 3 smaller 200% runs. I like the pipeline. Price hasn't been this low since 2013. I'll take my chances going long.

I bought some shares of BETRF today. Had the buy limit and it finally hit.

$BETRF / $BETR Emerging Growth Conference 16 Replay Available Now.

Registration link for the NEXT conference and Conference Replay link are here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165966391

$BETRF / $BETR Live on the Emerging Growth Conference in 30 minutes!

The Link to Register to Interact Live with the CEO's is here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165918728

Other Companies Presenting:
$SWISF / $SWIS
$LFAP / $LGBT
$FTXP
$ASCK
$TOMDF
$CYDY

Presented Earlier:
$NSAV
$EGLX
$AVCN / $AVCNF

$BETRF $BETR is presenting on Emerging Growth Conference 16 Today!

The Registration link to interact Live with the CEO is here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165918728

Companies Presenting:
$NSAV
$EGLX
$ILUS
$AVCN
$BETRF / $BETR
$SWISF / $SWIS
$LFAP / $LGBT
$FTXP
$ASCK
$TOMDF
$TPTW - Postponed to 9/29
$CYDY

$BETRF Better Life Pharma. CEO Live on the Emerging Growth Conference on September 15, 2021

Registration link to interact Live here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165842737

Who else would you like to see?
email:
Conference@EmergingGrowth.com
or
Call the number here:
http://EmergingGrowth.com/Conference

I'm trying to get in at .18

I don't think it's a falling knife but who knows? I like psychedelic stocks and they have a bunch of doctors who have names I cannot pronounce = buy!

I'll sell half when it doubles.

$BETRF Replay Emerging Growth 12/ IHub Conference:

Youtube Link and Next Conference Link Here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165086789

$PBIO
$CLNV
$CLIS
$BETRF
$BMIX
$DMAN
$TCFF
$YEG
$WNRS
$GROM

Who do you want to see on the next Conference?
Conference@EmergingGrowth.com

$BETRF CEO Live on the Emerging Growth / Investors Hub Conference in 30 minutes

Registration Link Here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165025662

Other Companies Presenting:
$BMIX
$DMAN
$PIXY
$TCFF
$YEG
$WNRS
$GROM

Currently Presenting:
$CLIS

Presented Previously:
$PBIO
$CLNV

$BETRF Live Today on the Emerging Growth 12 / Investors Hub Virtual Investor Conference

9:00 AM Eastern Time

Registration Link Here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=165021499

All of the Companies Presenting:
$PBIO
$CLNV
$CLIS
$BETRF
$BMIX
$DMAN
$PIXY
$TCFF
$YEG
$WNRS
$GROM

$BETRF on the Emerging Growth 12 / Investors Hub Conference
July 21, 2021

Register Here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164975844

Other Companies Presenting:
$CLIS
$BETRF
$BMIX
$DMAN
$PIXY
$TCFF
$YEG
$WNRS
$GROM

Who else would you like to see?

Conference@EmergingGrowth.com
-OR-
Call us at the number here:
https://emerginggrowth.com/conference/

$BETRF BetterLife Pharma Presenting Live on the Emerging Growth Conference on July 21, 2021

Registration Link Here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164911889

BetterLife believes that its inhaled IFN-a2b, AP-003, could lessen the severity and duration of COVID-19 and decrease the need for hospital admissions.
https://apple.news/Ab0L-9NLNTWmeAjGyiaBdJQ

Better Life Pharma is leading the charge against addiction! https://apple.news/AshTKSZCLSOmN4X_xbHf2MA

https://www.globenewswire.com/news-release/2021/01/04/2152745/0/en/BetterLife-Files-Patent-for-the-Treatment-of-MDD-Utilizing-its-Second-Generation-Psychedelic-Derivative-for-2-Bromo-LSD.html

https://theprovince.com/news/local-news/covid-19-b-c-researchers-continue-work-on-treatments-outside-limelight-of-vaccine-developments/wcm/022975c3-d88f-4623-8e7b-221d074161d9

https://www.globenewswire.com/news-release/2020/12/29/2151049/0/en/BetterLife-Pharma-Strengthens-Board-of-Directors.html

https://www.globenewswire.com/news-release/2020/12/23/2149783/0/en/BetterLife-Welcomes-Psychedelic-Industry-Leaders-to-the-Senior-Management-Team.html

This POS stock has no ability to recover.
I don’t think they will ever start those trials.
Looks like insiders are selling.

David.

Did you see the news today?
Hiring PR for $50,000 up front and over $20,000 per month?
That is highway robbery.

David.

Absolutely pathetic. I’m worried that the unveiling of the vaccines will/or have already killed any prospects of this one.

Horrible trading so far.

David

NIA better pump this back up.

Doesn’t look good. Early morning news is usually good.
Probably a financing which would be a stock killer.

David

Any ideas why it’s halted?

Halted.
Guess we find out tomorrow.

David

News out$.
https://www.globenewswire.com/news-release/2020/07/30/2070265/0/en/BetterLife-Pharma-Receives-Approval-from-Altum-Pharmaceuticals-Inc-Shareholders-to-Complete-Merger.html

Agreed.

This is the only interferon nebulizer stock on the American exchanges.
At least that I could find.
Once they announce news about starting trials it should move higher.
I am concerned about the lack of awareness surrounding this stock.
Hope that changes.

David.

Just getting started here. Could easily hit $10-$30/share IMO. Look at ALT

Interesting news.
Recent news from London stock showing benefits from inhaled interferon.
This should help get exposure to Betterlife.
Nice movement last 2 days.
Low float. Low market cap.

David.

BETRF: effective June 26,2020 a one for 10 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

Effective June 9,2020 Pivot Pharmaeuticals Inc., PVOTF, will change to Betterlife Pharma Inc., BETRF:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

PVOTF Daily Chart

News - Pivot Pharma enters US CBD market with its proprietary CBD product line
Canada NewsWire

VANCOUVER, Oct. 8, 2019

VANCOUVER, Oct. 8, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT/ OTCQB: PVOTF/ FRA: NPAT) has entered into a contract manufacturing and supply agreement with F&B Cosmetics to manufacture Pivot's differentiated portfolio of CBD based wellness products in the United States

Pivot will enter the US market in Q1 2020 with its differentiated CBD based products using Pivot's patented technologies. Pivot recognizes the importance of creating a market leading brand and Pivot is actively working with Joseph Mimran & Associates to brand and market the Pivot products in North America.

Pivot's ultimate goal is to be a market leader in the emerging phytocannabinoids medical wellness market offering comprehensive science based solutions of preventive and self-care treatment to our customers.

"Pivot's future lies in the successful launch of its differentiated CBD product line using Pivot's patented technologies along with customer acceptance of its superior and proprietary phytocannabinoids products," said Dr. Rinow, CEO of Pivot. "With our team of scientists Pivot is focused on the development of value-added CBD and nutraceutical products. Pivot also embraces the ethical responsibility of offering high quality, premium branded products. Pivot's superior products when combined with the branding created by Joseph Mimran & Associates positions Pivot to create a portfolio of world class phytocannabanoid products in the US, Europe and Canada."

About F&B Cosmetics
F&B Cosmetics is a full service FDA registered, cGMP compliant contract manufacturer of premium products from its 125,000 square feet state of the art facility. Based in Tennessee. F&B is servicing some of the largest cosmetic companies in the world.

About Pivot Pharmaceuticals Inc.
Pivot Pharmaceuticals Inc. is a science-based innovative medical wellness company aspiring to offer high quality preventive and self-care solutions to its customers. Pivot has developed pharmaceutical grade products including CBD, phytocannabinoids and nutraceutical products utilizing proprietary delivery technologies that are unique, patent protected with clear superior benefits to the user such as high absorption, low bioburden and ease of use. Pivot is uniquely positioned to execute on its brand leader strategy in its main markets in Germany, US and Canada.

Higher openings everyday, abt to breakout of this range $PVOTF

Joe Mimran to Join Advisory Committee; Krisztian Toth Appointed to Board of Directors
VANCOUVER, April 9, 2019 /CNW/ - Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) ("Pivot" or the "Company") is pleased to announce that it has signed a Binding Letter of Intent, dated  April 8, 2019, with High Park Ventures Inc. ("HPK" or "High Park Ventures"), a private investment company, for a non-brokered private placement of $15 million. The private placement will be of units at a price of $0.25 per unit, with each unit consisting of one common share and one common share purchase warrant ("Warrants") having a term of two years and an exercise price of $0.35. The private placement is expected to close in two tranches, with the first closing of $5 million within two weeks and the second tranche of $10 million closing within four weeks. Upon completion of the non-brokered private placement Pivot will issue 60,000,000 units to HPK.  Completion of the private placement is conditional on HPK satisfactorily completing its due diligence investigation and High Park Ventures and Pivot entering into an advisory agreement pursuant to which High Park Ventures will provide Pivot with strategic advice.


?

High Park Ventures is a private investment company with a focus on US investments, whose chairman is renowned entrepreneur Joe Mimran. Upon completion of the closing, Joe Mimran will join Pivot's advisory committee and will provide strategic advice to Pivot. Mr. Mimran is Co-founder and Chairman of Gibraltar and Company, and an internationally recognized brand and retail concept visionary known for brands such as Joe Fresh and Club Monaco. Krisztian Toth, the Chief Executive Officer of High Park Ventures, will join the Board of Pivot on the closing date.  The High Park Ventures team previously founded NettaGrowth International Inc. ("NettaGro"), who through Dormul S.A. obtained the first license to produce medical cannabis with THC for commercialization in Uruguay. NettaGro was sold to Khiron Life Sciences Corp. on January 25, 2019.
Pivot's CEO, Dr. Patrick Frankham stated, "We are thrilled to welcome Joe Mimran to Pivot's advisory committee and receive the investment from High Park Ventures. With the investment and support provided by the High Park Ventures Team, we are able to implement and accelerate our initiatives. I would also like to welcome Krisztian Toth to Pivot's Board of Directors. The experience and track record of the High Park Ventures Team will greatly benefit Pivot's management team as we commercialize our industry leading bio-cannabis product line."
Krisztian Toth, CEO of High Park Ventures Inc., "We are excited to work with the Pivot Team and assist them with the development, commercialization and branding of premium quality cannabinoid-based nutraceuticals and pharmaceuticals and leveraging the worldwide rights of their patented drug delivery technologies."
About Pivot Pharmaceuticals Inc.
Pivot Pharmaceuticals Inc. is a science-based consumer packaged goods cannabis company engaged in the development and commercialization of health and wellness products using innovative, patent-protected drug delivery technologies. Upon receipt of a Standard Processor license (pending) from Health Canada, Pivot's premium, bioavailable, stable and effective products will be manufactured at its 50,000-sq. ft. cGMP facility located in Montreal, Quebec. Pivot's wholly-owned U.S. subsidiary, Pivot Naturals, LLC, based in Costa Mesa, California, was granted a Temporary Manufacturing Type N: Infusion License by the California Department of Public Health in November 2018. Pivot's product line includes infused beverages, vegan capsules, dissolvable tablets, topical creams and gels, intimate lubricants, roll-on pain relievers, stick packs, and bulk powder for the edibles market. For more information please visit pivotpharma.com 
Cautionary Note Regarding Forward-Looking Statements
Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as anticipate, believe, estimate, expect, intend, and similar expressions, as they relate to Pivot Pharmaceuticals Inc., Pivot Green Stream Health Solutions Inc., Pivot Naturals, LLC, or its management or the completion of the private placement, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, such as the failure to close the private placement, meet the conditions imposed by the CSE or other securities regulators, the level of business and consumer spending, the amount of sales of Pivot's products, statements with respect to internal expectations, the competitive environment within the industry, the ability of Pivot to continue to expand its operations, the level of costs incurred in connection with Pivot's expansion efforts, economic conditions in the industry, and the financial strength of Pivot's customers and suppliers. Pivot does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.

NEWS WITH EMH! https://www.ftmig.com/cannabis/emerald-health-therapeutics-announces-discharge-of-litigation/

NEWS!! https://www.ftmig.com/cannabis/pivot-pharma-signs-contract-manufacturing-agreement-with-growpacker-inc/

The Dilemma of a Perfectionist

Privacy is a key component of concentration. Pivot’s primary focus is upon perfecting their product line. Just as a doctor directs his sole attention to his patients. It is no surprise that Pivot’s Team is comprised of exceptional minds in the field of medicine. Therefore, marketing and financial management take a back seat. Doctors listen to their patients and provide unique solutions. Doctors do not market their research from the rooftops instead it’s written in their study. Pivot’s website is full of knowledge yet those with biology, chemistry, and the such majors are able to navigate through. Pivot needs to tailor their marketing as to not alienate those without a doctorate. I know their products will be perfect, but that should not prevent them from making those leaps into commercialization. Expansion begins with the first contact.

Oh it really has begun
"Pivot Secures Supply of Pharmaceutical Grade CBD Isolate from PURE Holding AG" From Yahoo Financial. Hopefully you have read it already It is beautiful. Gives the credit that is due and seems to be setting up something even bigger in my mind. Best Purest Cleanest and the Cherry on top "Pivot's products are unmatched in the industry". I was hoping for some news today and this was beyond Great.

Sweet thank you for the post been waiting for some new news especially more good news. It starting to feel like its almost time for pivot to start taking over this part of the market. I still haven't seen any one with tech like theirs. No one has a true tasteless odorless colorless water soluble product like pivot. I still feel and think coke is a possibility for CBD from pivot it is everything they said they wanted in their CBD Coke.

NEWS!! https://www.ftmig.com/cannabis/pivot-announces-completion-of-definitive-agreement-with-cartagena-inc/

NEWS!! https://www.ftmig.com/cannabis/pivot-naturals-llc-receives-three-additional-notices-of-allowance-from-uspto/

NEWS!! https://www.ftmig.com/cannabis/pivot-completes-c1-64-million-non-brokered-private-placement/

$PVOTF - Ready for the run!

Happy Trading!